{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:29:38Z","timestamp":1790990978811,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dental Clinics of North America"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.cden.2023.07.005","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T09:09:32Z","timestamp":1693386572000},"page":"67-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Treatment of Medication-Related Osteonecrosis of the Jaw"],"prefix":"10.1016","volume":"68","author":[{"given":"Leslie Robin","family":"Halpern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Russell","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cden.2023.07.005_bib1","doi-asserted-by":"crossref","first-page":"IX","DOI":"10.1016\/j.coms.2017.09.001","article-title":"Controversies in oral and maxillofacial surgery: Preface","volume":"29","author":"Vega","year":"2017","journal-title":"Oral Maxillofac Surg Clin NA"},{"key":"10.1016\/j.cden.2023.07.005_bib2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/antiox10050680","article-title":"Various therapeutic methods for the treatment of medication-related osteonecrosis of the jaw (MRONJ) and their limitations: A narrative review on new molecular and cellular therapeutic approaches","volume":"10","author":"On","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"10.1016\/j.cden.2023.07.005_bib3","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022\u00a0Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"Oral Maxillofac Surg"},{"issue":"11","key":"10.1016\/j.cden.2023.07.005_bib4","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.joms.2022.07.149","article-title":"Comment Re: AAOMS position paper on Medication-related osteonecrosis of the jaw-2022 update","volume":"80","author":"Campisi","year":"2022","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"7","key":"10.1016\/j.cden.2023.07.005_bib5","first-page":"CD012432","article-title":"Interventions for managing medication-related osteonecrosis of the jaw (Review)","volume":"7","author":"Beth-Tasdogan","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cden.2023.07.005_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","article-title":"Evidence-based medicine: what it is and what it isn\u2019t","volume":"312","author":"Sackett","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.cden.2023.07.005_bib7","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.cden.2023.07.005_bib8","unstructured":"Available at: https:\/\/news.bloomberglaw.com\/product-liability-and-toxics-law\/novartis-wins-judgment-in-jaw-decay-suit-allegedly-faulty-warning-didnt-cause-harm."},{"key":"10.1016\/j.cden.2023.07.005_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.joms.2009.01.009","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.cden.2023.07.005_bib10","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"38","key":"10.1016\/j.cden.2023.07.005_bib11","first-page":"1","article-title":"Current controversies on the pathogenesis of medication-related osteonecrosis of the jaw","volume":"4","author":"Wat","year":"2016","journal-title":"Dent J"},{"key":"10.1016\/j.cden.2023.07.005_bib12","first-page":"CD012432","article-title":"Interventions for managing medication-related osteonecrosis of the jaw","volume":"7","author":"Beth-Tasdogan","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cden.2023.07.005_bib13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00198-017-4345-0","article-title":"Hip fracture trends in the United States, 2002 to 2015","volume":"29","author":"Lewiecki","year":"2018","journal-title":"Osteoporosis Int"},{"issue":"11","key":"10.1016\/j.cden.2023.07.005_bib14","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1177\/154405910708601101","article-title":"Osteonecrosis of the jaw and bisphosphonate therapy","volume":"86","author":"Ruggiero","year":"2007","journal-title":"J\u00a0Dent Res"},{"key":"10.1016\/j.cden.2023.07.005_bib15","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cden.2023.07.005_bib16","first-page":"366","article-title":"Bone sequestration from lower 3rd molar region","volume":"193","author":"Friel","year":"2002","journal-title":"Br Dent J"},{"key":"10.1016\/j.cden.2023.07.005_bib17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bjoms.2005.05.012","article-title":"Extensive maxillary sequestration resulting from mucormycosis","volume":"43","author":"Huang","year":"2005","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.cden.2023.07.005_bib18","first-page":"71","article-title":"American Academy of Oral and Maxillofacial Pathology. Persistent painful ulcer of the posterior lingual mandibular mucosa","volume":"4","author":"Peters","year":"2003","journal-title":"J\u00a0Contemp Dent Pract"},{"issue":"47","key":"10.1016\/j.cden.2023.07.005_bib19","article-title":"Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review","volume":"7","author":"Kawahara","year":"2021","journal-title":"Int J Implant Dent"},{"key":"10.1016\/j.cden.2023.07.005_bib20","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1210\/jc.2018-01965","article-title":"Invasive oral procedures and events in postmenopausal women with osteoporosis treated with denosumab for up to 10 years","volume":"104","author":"Watts","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cden.2023.07.005_bib21","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ijom.2012.06.020","article-title":"Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: A cohort study","volume":"41","author":"Yamazaki","year":"2012","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.cden.2023.07.005_bib22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jcms.2015.02.018","article-title":"Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction","volume":"43","author":"Bodem","year":"2015","journal-title":"J\u00a0Cranio-Maxillofacial Surg"},{"key":"10.1016\/j.cden.2023.07.005_bib23","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: Integrative analyses from three-blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.cden.2023.07.005_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1563\/aaid-joi-D-19-00351","article-title":"Dental implant placement in patients with a history of medication related osteonecrosis of the jaw: A systematic review","volume":"67","author":"Sher","year":"2021","journal-title":"J\u00a0Oral Implantol"},{"key":"10.1016\/j.cden.2023.07.005_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/odi.12708","article-title":"Risk factors for medication-related osteonecrosis of the jaws: A systematic review","volume":"24","author":"Mcgowan","year":"2018","journal-title":"Oral Dis"},{"issue":"1 Suppl","key":"10.1016\/j.cden.2023.07.005_bib26","first-page":"851","article-title":"Alveolar bone and the bisphosphonates","volume":"54","author":"Cheng","year":"2009","journal-title":"Aust Dent J"},{"key":"10.1016\/j.cden.2023.07.005_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jbmr.2985","article-title":"IL-36 induces bisphosphonate-related osteonecrosis of the jaw- Like lesions in mice by inhibiting TGF-b-mediated collagen expression","volume":"32","author":"Kim","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.cden.2023.07.005_bib28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/RCT.0b013e31817e4986","article-title":"Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings","volume":"33","author":"Krishnan","year":"2009","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.cden.2023.07.005_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.micpath.2010.11.002","article-title":"Oral biofilm challenge regulates the RANKL-OPG system in periodontal ligament and dental pulp cells","volume":"50","author":"Belibasakis","year":"2011","journal-title":"Microb Pathog"},{"key":"10.1016\/j.cden.2023.07.005_bib30","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMcpc0800341","article-title":"Case records of the Massachusetts General Hospital Case-9-2008. A 65-year-old woman with a nonhealing ulcer of the jaw","volume":"358","author":"Dodson","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cden.2023.07.005_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17165998","article-title":"Medication-related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian consensus update 2020","volume":"17","author":"Campisi","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"10.1016\/j.cden.2023.07.005_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","article-title":"Medicaiotn- related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment","volume":"127","author":"Nicolatou-Galitis","year":"2019","journal-title":"Oral surg Oral Path Oral Med Oral Radiol"},{"key":"10.1016\/j.cden.2023.07.005_bib33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1200\/JOP.19.00645","article-title":"Comment on medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical Practice Guideline summary","volume":"16","author":"Fuco","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.cden.2023.07.005_bib34","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s00198-017-4063-7","article-title":"A\u00a0multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonates therapy: Can primary wound closure and a drug holiday really prevent MRONJ?","volume":"28","author":"Hasegawa","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.cden.2023.07.005_bib35","doi-asserted-by":"crossref","first-page":"e03795","DOI":"10.1016\/j.heliyon.2020.e03795","article-title":"Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A s systematic review","volume":"6","author":"Ottesen","year":"2020","journal-title":"Heliyon"},{"issue":"25","key":"10.1016\/j.cden.2023.07.005_bib36","first-page":"1","article-title":"a pragmatic window of opportunity to minimize the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis","volume":"75","author":"Campisi","year":"2021","journal-title":"Head Face Med"},{"issue":"11","key":"10.1016\/j.cden.2023.07.005_bib37","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.oraloncology.2014.08.016","article-title":"A\u00a0systematic review of therapeutic approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ)","volume":"50","author":"Rupel","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.cden.2023.07.005_bib38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00784-017-2325-6","article-title":"stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: A systematic review and meta- analysis of the drug suspension protocol","volume":"22","author":"Ramaglia","year":"2018","journal-title":"Clin Oral investigat"},{"key":"10.1016\/j.cden.2023.07.005_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","article-title":"The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Carlson","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.cden.2023.07.005_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tripleo.2010.04.015","article-title":"The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw","volume":"111","author":"Wilde","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.cden.2023.07.005_bib41","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.joms.2013.05.014","article-title":"Metastatic cancer identified in osteonecrosis specimens of the jaws in patients receiving intravenous bisphosphonate medications","volume":"71","author":"Carlson","year":"2013","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.cden.2023.07.005_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115676","article-title":"Adjuvant therapies for MRONJ: A systematic review","author":"Govaerts","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.cden.2023.07.005_bib43","first-page":"b147","article-title":"Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: A review of 282 patients","volume":"77","author":"Bonacina","year":"2011","journal-title":"J\u00a0Can Dent Assoc"},{"key":"10.1016\/j.cden.2023.07.005_bib44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00223-018-0485-2","article-title":"Reduction in hip and other fractures on patients receiving Teriparatide in real-world clinical practice : Integratedb analysis of four prospective observational studies","volume":"104","author":"Silverman","year":"2019","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.cden.2023.07.005_bib45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.oooo.2019.08.004","article-title":"Systematic review of the use of pentoxifylline and tocopherol for the treatment of medication -related osteonecrosis of the jaw","volume":"128","author":"Heifetz-Li","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.cden.2023.07.005_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.archoralbio.2022.105397","article-title":"Effect of pentoxifylline and alpha-tocopherol on medication-related osteonecrosis of the jaw in rats: Before and after dental extraction","volume":"137","author":"Delfrate","year":"2022","journal-title":"Arch Oral Biol"}],"container-title":["Dental Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011853223001179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011853223001179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T01:24:12Z","timestamp":1757899452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011853223001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0011853223001179"],"URL":"https:\/\/doi.org\/10.1016\/j.cden.2023.07.005","relation":{},"ISSN":["0011-8532"],"issn-type":[{"value":"0011-8532","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Medication-Related Osteonecrosis of the Jaw","name":"articletitle","label":"Article Title"},{"value":"Dental Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cden.2023.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}